Zofia E. Dziewanowska, VP, Clinical Research at LIGAND PHARMACEUTICALS INC (LGND), sold 6,000 shares at $2.62 ($16K) on 2009-02-25, disclosed to the SEC on 2009-02-27.
Open-market sale of $16k LGND by VP, Clinical Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.